Testim Bellwether Plaintiff: Off-Label Evidence Probative, New Trial Sought

(December 18, 2017, 1:51 PM EST) -- CHICAGO — A plaintiff who lost his testosterone replacement therapy case on Dec. 14 asked an Illinois federal court for a new trial, arguing that the court erred by excluding evidence the plaintiff says shows that defendant Auxilium Pharmaceuticals LLC pushed off-label sales of the drug Testim to get more sales and profits (In Re:  Testosterone Replacement Therapy Products Liability Litigation, MDL Docket No. 2545, No. 14-1748, Steve Holtsclaw v. Auxilium Pharmaceuticals, LLC, et al., No. 15-3941, N.D. Ill.)....

Attached Documents

Related Sections